This inventor holds 12 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Medshine Discovery Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical Holdings Company Limited. Active years: 2021-2026.
Company Filing History:
3 out of 72 
1 out of 121 
1 out of 2 
Years Active: 2021-2026
Title: Lele Zhao: Innovator in Pharmaceutical Compounds
Introduction
Lele Zhao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.
Latest Patents
Among his latest patents is the invention of pyrrolotriazine compounds acting as MNK inhibitors. These compounds are designed to inhibit mitogen-activated protein kinase interacting kinase (MNK), which is crucial in the development of new drugs targeting various diseases. Another notable patent involves an acetophenone oxime compound, which includes a preparation method and its pharmaceutically acceptable salts.
Career Highlights
Lele Zhao has worked with several reputable companies in the pharmaceutical industry. Notably, he has been associated with Medshine Discovery Inc. and Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His experience in these organizations has allowed him to advance his research and development efforts significantly.
Collaborations
Throughout his career, Lele Zhao has collaborated with talented professionals, including Lingyun Wu and Shuhui Chen. These collaborations have contributed to the successful development of his patented inventions.
Conclusion
Lele Zhao's innovative work in pharmaceutical compounds showcases his dedication to advancing medical science. His contributions through patents and collaborations highlight his role as a key inventor in the industry.